Inhaled Budesonide for Viral-Induced Wheeze in Children Under 4 Years

Dosing Recommendations

For children under 4 years with viral-induced wheeze, the American Academy of Pediatrics recommends a dose of 0.25-0.5 mg twice daily for maintenance therapy, or 1 mg twice daily for 7 days when used intermittently at the onset of respiratory tract infection symptoms 1, 2, 3
The recommended low daily dose for maintenance therapy is 0.25-0.5 mg/day of budesonide nebulizer suspension, as suggested by the American Thoracic Society 1, 2
Budesonide is the only inhaled corticosteroid with FDA-approved labeling for children under 4 years of age, according to the American Academy of Allergy, Asthma, and Immunology 1, 4

Children under 4 years generally require delivery of inhaled corticosteroids through a face mask that should fit snugly over nose and mouth, as recommended by the American Academy of Pediatrics 1, 2
The most important determinant of appropriate dosing is the clinician's judgment of the patient's response to therapy, with a strength of evidence rated as high certainty by the American Thoracic Society 1, 2
Monitor the patient's response on several clinical parameters and adjust the dose accordingly, as suggested by the American Academy of Allergy, Asthma, and Immunology 1, 2

Potential adverse effects include cough, dysphonia, and oral thrush (candidiasis), with a strength of evidence rated as moderate by the American Academy of Allergy, Asthma, and Immunology 1, 2
In low-to-medium doses, suppression of growth velocity has been observed in children, but this effect may be transient; the clinical significance has not been established, according to the American Academy of Pediatrics 1, 2
The safety and efficacy of inhaled corticosteroids in children under 1 year has not been established, as noted by the American Academy of Allergy, Asthma, and Immunology 1, 2

For recurrent wheezing triggered by respiratory tract infections with no wheezing between infections, the American Thoracic Society conditionally recommends 1 mg twice daily for 7 days at the first sign of respiratory infection symptoms, with a strength of evidence rated as high certainty 3, 5
This approach is conditionally recommended with high certainty of evidence for children who have had three or more episodes of wheezing triggered by respiratory infections in their lifetime or two episodes in the past year, as suggested by the American Academy of Allergy, Asthma, and Immunology 3, 5